NPM Capital N.V.

Investment Manager at NPM Capital serving as the contact for the Probo investment, supporting the company's upscaling and international expansion.

Chantal Stoffelsma is an Investment Director at NPM Capital in Amsterdam. She transitioned to private equity in 2017 after six years as a strategy consultant at Bain & Company serving European clients, during which she completed an MBA at INSEAD in Singapore. At NPM, she has been involved in investments across healthcare and mobility sectors, including positions with Otolift, Het Gastenhuis, and Medux.

Anne Hellemans is a tax accountant at NPM Capital, where she works within the Tax Governance team on tax strategy execution and improvement initiatives. Her responsibilities include tax accounting and reporting, global tax governance aligned with Dutch tax positions, and tax technology implementation including compliance tracking and pillar two matters.

Jeroen Krijnen is Manager of Finance Transformation at NPM Capital, where he leads IFRS implementation and related finance initiatives. A registered accountant with over 20 years of experience, he has worked across auditing, accounting, financial reporting, and controlling, including consolidated IFRS financial statement preparation for listed multinationals and group audit planning. His technical expertise encompasses IFRS and Dutch GAAP standards, SAP-BPC consolidation systems, internal control evaluation, and team leadership.

Maarten Heijmans is Manager of Procurement Services at NPM Capital. He has experience in procurement within the food and feed production industry, with expertise in strategic sourcing, supply management, and purchasing processes. He holds training in strategic procurement from Nevi.

Martijn Bras is General Counsel at NPM Capital, where he works as a corporate lawyer with a focus on private equity matters.

Investment Director at NPM Capital, involved with portfolio companies HQ Pack and Dieseko in the Digital & Technology segment.

Dirk Reyn is Advisor and Managing Partner of Bioqube Factory Fund I with over 35 years of leadership in pharma and biotech. He began at Eli Lilly and Janssen-Cilag (J&J), co-founded and led Movetis NV to IPO and acquisition by Shire, founded Progress Pharma, and chaired Flanders.bio.

Senior Payments Manager at Burberry, leading global retail payment strategy using omni-channel and blockchain technology, with a career in banking and payments.

Operational leader driving strategy, capital formation, and execution across KIC Ventures and LESS Society, including Series A coordination and investor relations infrastructure.